Vocabulary Frequencies Per Genes
Download Table (.CSV)| Gene | N | Feature | Count | Frequency |
|---|---|---|---|---|
| HGNC:9752 QDPR | 2 | MHO:000013 Unequal Size | 2 | 1.00 |
| HGNC:9752 QDPR | 2 | MHO:000072 Necklace Fibers | 2 | 1.00 |
| HGNC:9752 QDPR | 2 | MHO:000027 Centralized Nuclei | 2 | 1.00 |
| HGNC:9752 QDPR | 2 | MHO:000083 Predominance Fiber Type 1 | 2 | 1.00 |
| HGNC:9752 QDPR | 2 | MHO:000107 Structural Disorganisation | 2 | 1.00 |
| HGNC:9752 QDPR | 2 | MHO:000021 Rounded edge | 2 | 1.00 |
| HGNC:9752 QDPR | 2 | MHO:000029 Sub-Sarcolemmal Nuclei | 2 | 1.00 |
| HGNC:9752 QDPR | 2 | MHO:000030 Nuclei with Myotubular Aspects | 2 | 1.00 |
| HGNC:9752 QDPR | 2 | MHO:000028 Internalized nuclei | 2 | 1.00 |
| HGNC:9752 QDPR | 2 | MHO:000006 Fiber Type 1 Atrophied | 1 | 0.50 |
| HGNC:9752 QDPR | 2 | MHO:000010 Fiber Type 2 Atrophied | 1 | 0.50 |
| HGNC:9752 QDPR | 2 | MHO:000031 Increase in the number of nuclei | 1 | 0.50 |
| HGNC:9752 QDPR | 2 | MHO:000070 Increase in Endosymal Collagen | 1 | 0.50 |
| HGNC:9752 QDPR | 2 | MHO:000091 Central ATP activity | 1 | 0.50 |
| HGNC:9752 QDPR | 2 | MHO:000081 Type Uniformity | 1 | 0.50 |
| HGNC:1052 BIN1 | 1 | MHO:000006 Fiber Type 1 Atrophied | 1 | 1.00 |
| HGNC:1052 BIN1 | 1 | MHO:000113 Clear zone (pale) | 1 | 1.00 |
| HGNC:1052 BIN1 | 1 | MHO:000128 Cores over the whole Section | 1 | 1.00 |
| HGNC:1052 BIN1 | 1 | MHO:000127 Cores with Blurred Boundaries | 1 | 1.00 |
| HGNC:1052 BIN1 | 1 | MHO:000126 Cores with Net Limits | 1 | 1.00 |
| HGNC:1052 BIN1 | 1 | MHO:000129 Minicores | 1 | 1.00 |
| HGNC:1052 BIN1 | 1 | MHO:000124 Peripheral Cores | 1 | 1.00 |
| HGNC:1052 BIN1 | 1 | MHO:000125 Single Central Core | 1 | 1.00 |
| HGNC:1052 BIN1 | 1 | MHO:000083 Predominance Fiber Type 1 | 1 | 1.00 |
| HGNC:1052 BIN1 | 1 | MHO:000027 Centralized Nuclei | 1 | 1.00 |
| HGNC:1052 BIN1 | 1 | MHO:000013 Unequal Size | 1 | 1.00 |
| HGNC:1052 BIN1 | 1 | MHO:000107 Structural Disorganisation | 1 | 1.00 |
| HGNC:1052 BIN1 | 1 | MHO:000015 No Topography | 1 | 1.00 |
| HGNC:1052 BIN1 | 1 | MHO:000105 Core-like alveolus | 1 | 1.00 |
| N/A | 8 | MHO:000006 Fiber Type 1 Atrophied | 5 | 0.62 |
| N/A | 8 | MHO:000027 Centralized Nuclei | 5 | 0.62 |
| N/A | 8 | MHO:000048 Rods | 4 | 0.50 |
| N/A | 8 | MHO:000010 Fiber Type 2 Atrophied | 4 | 0.50 |
| N/A | 8 | MHO:000107 Structural Disorganisation | 4 | 0.50 |
| N/A | 8 | MHO:000028 Internalized nuclei | 3 | 0.38 |
| N/A | 8 | MHO:000083 Predominance Fiber Type 1 | 3 | 0.38 |
| N/A | 8 | MHO:000013 Unequal Size | 3 | 0.38 |
| N/A | 8 | MHO:000005 Fiber Type 1 Hypertrophic | 3 | 0.38 |
| N/A | 8 | MHO:000036 Dark clusters | 3 | 0.38 |
| N/A | 8 | MHO:000031 Increase in the number of nuclei | 2 | 0.25 |
| N/A | 8 | MHO:000072 Necklace Fibers | 2 | 0.25 |
| N/A | 8 | MHO:000081 Type Uniformity | 2 | 0.25 |
| N/A | 8 | MHO:000074 Necrosis | 2 | 0.25 |
| N/A | 8 | MHO:000040 Fuscinophilic material: Centralized | 2 | 0.25 |
| N/A | 8 | MHO:000059 Fibrous connective tissue | 2 | 0.25 |
| N/A | 8 | MHO:000106 Structural Reorganisation | 2 | 0.25 |
| N/A | 8 | MHO:000009 Fiber Type 2 Hypertrophic | 2 | 0.25 |
| N/A | 8 | MHO:000011 Fiber Type 2 Heterogeneous size | 2 | 0.25 |
| N/A | 8 | MHO:000007 Fiber Type 1 Heterogeneous size | 2 | 0.25 |
| N/A | 8 | MHO:000136 Local Abnormal COX activity | 1 | 0.12 |
| N/A | 8 | MHO:000135 Abnormal COX activity | 1 | 0.12 |
| N/A | 8 | MHO:000008 Fiber Type 2 | 1 | 0.12 |
| N/A | 8 | MHO:000004 Fiber Type 1 | 1 | 0.12 |
| N/A | 8 | MHO:000050 Red Spike | 1 | 0.12 |
| N/A | 8 | MHO:000174 Normal Situation | 1 | 0.12 |
| N/A | 8 | MHO:000060 Lipomatous connective tissue | 1 | 0.12 |
| N/A | 8 | MHO:000075 Regeneration | 1 | 0.12 |
| N/A | 8 | MHO:000033 Centralized Inclusions | 1 | 0.12 |
| N/A | 8 | MHO:000030 Nuclei with Myotubular Aspects | 1 | 0.12 |
| N/A | 8 | MHO:000073 Peripheral nail stroke | 1 | 0.12 |
| N/A | 8 | MHO:000003 Abnormal Biopsy | 1 | 0.12 |
| N/A | 8 | MHO:000029 Sub-Sarcolemmal Nuclei | 1 | 0.12 |
| N/A | 8 | MHO:000051 Red Dust | 1 | 0.12 |
| N/A | 8 | MHO:000045 Fuscinophilic material: Rounded | 1 | 0.12 |
| N/A | 8 | MHO:000044 Fuscinophilic material: Irregular edges | 1 | 0.12 |
| N/A | 8 | MHO:000109 Irregular Intermyofibrillar Network | 1 | 0.12 |
| N/A | 8 | MHO:000110 Rimmed Sarcolemma | 1 | 0.12 |
| N/A | 8 | MHO:000041 Fuscinophile matrial: Peripherals | 1 | 0.12 |
| N/A | 8 | MHO:000021 Rounded edge | 1 | 0.12 |
| N/A | 8 | MHO:000129 Minicores | 1 | 0.12 |
| N/A | 8 | MHO:000057 Abnormal Neuromuscular Spindle | 1 | 0.12 |
| N/A | 8 | MHO:000122 Peripheral Mitochondrial Accumulation | 1 | 0.12 |
| HGNC:12403 TTN | 5 | MHO:000013 Unequal Size | 5 | 1.00 |
| HGNC:12403 TTN | 5 | MHO:000083 Predominance Fiber Type 1 | 5 | 1.00 |
| HGNC:12403 TTN | 5 | MHO:000114 Central activity | 4 | 0.80 |
| HGNC:12403 TTN | 5 | MHO:000010 Fiber Type 2 Atrophied | 4 | 0.80 |
| HGNC:12403 TTN | 5 | MHO:000081 Type Uniformity | 4 | 0.80 |
| HGNC:12403 TTN | 5 | MHO:000006 Fiber Type 1 Atrophied | 3 | 0.60 |
| HGNC:12403 TTN | 5 | MHO:000063 Interstitial Connective Tissue Increase | 3 | 0.60 |
| HGNC:12403 TTN | 5 | MHO:000129 Minicores | 2 | 0.40 |
| HGNC:12403 TTN | 5 | MHO:000127 Cores with Blurred Boundaries | 2 | 0.40 |
| HGNC:12403 TTN | 5 | MHO:000027 Centralized Nuclei | 2 | 0.40 |
| HGNC:12403 TTN | 5 | MHO:000059 Fibrous connective tissue | 2 | 0.40 |
| HGNC:12403 TTN | 5 | MHO:000070 Increase in Endosymal Collagen | 2 | 0.40 |
| HGNC:12403 TTN | 5 | MHO:000107 Structural Disorganisation | 2 | 0.40 |
| HGNC:12403 TTN | 5 | MHO:000105 Core-like alveolus | 2 | 0.40 |
| HGNC:12403 TTN | 5 | MHO:000113 Clear zone (pale) | 2 | 0.40 |
| HGNC:12403 TTN | 5 | MHO:000036 Dark clusters | 2 | 0.40 |
| HGNC:12403 TTN | 5 | MHO:000118 Blurred boundaries | 2 | 0.40 |
| HGNC:12403 TTN | 5 | MHO:000028 Internalized nuclei | 2 | 0.40 |
| HGNC:12403 TTN | 5 | MHO:000048 Rods | 1 | 0.20 |
| HGNC:12403 TTN | 5 | MHO:000124 Peripheral Cores | 1 | 0.20 |
| HGNC:12403 TTN | 5 | MHO:000128 Cores over the whole Section | 1 | 0.20 |
| HGNC:12403 TTN | 5 | MHO:000087 Fibres 1 Grouped | 1 | 0.20 |
| HGNC:12403 TTN | 5 | MHO:000095 Abnormal ATPase activity | 1 | 0.20 |
| HGNC:12403 TTN | 5 | MHO:000003 Abnormal Biopsy | 1 | 0.20 |
| HGNC:12403 TTN | 5 | MHO:000096 Locally Abnormal ATP Activity (Clear Zone) | 1 | 0.20 |
| HGNC:12403 TTN | 5 | MHO:000015 No Topography | 1 | 0.20 |
| HGNC:12403 TTN | 5 | MHO:000151 Sudan Staining: Abornmal (Lipids Overload) | 1 | 0.20 |
| HGNC:12403 TTN | 5 | MHO:000125 Single Central Core | 1 | 0.20 |
| HGNC:129 ACTA1 | 3 | MHO:000006 Fiber Type 1 Atrophied | 3 | 1.00 |
| HGNC:129 ACTA1 | 3 | MHO:000013 Unequal Size | 3 | 1.00 |
| HGNC:129 ACTA1 | 3 | MHO:000083 Predominance Fiber Type 1 | 2 | 0.67 |
| HGNC:129 ACTA1 | 3 | MHO:000009 Fiber Type 2 Hypertrophic | 2 | 0.67 |
| HGNC:129 ACTA1 | 3 | MHO:000096 Locally Abnormal ATP Activity (Clear Zone) | 2 | 0.67 |
| HGNC:129 ACTA1 | 3 | MHO:000015 No Topography | 2 | 0.67 |
| HGNC:129 ACTA1 | 3 | MHO:000107 Structural Disorganisation | 2 | 0.67 |
| HGNC:129 ACTA1 | 3 | MHO:000113 Clear zone (pale) | 2 | 0.67 |
| HGNC:129 ACTA1 | 3 | MHO:000010 Fiber Type 2 Atrophied | 2 | 0.67 |
| HGNC:129 ACTA1 | 3 | MHO:000116 Crescent shape | 1 | 0.33 |
| HGNC:129 ACTA1 | 3 | MHO:000124 Peripheral Cores | 1 | 0.33 |
| HGNC:129 ACTA1 | 3 | MHO:000048 Rods | 1 | 0.33 |
| HGNC:129 ACTA1 | 3 | MHO:000011 Fiber Type 2 Heterogeneous size | 1 | 0.33 |
| HGNC:129 ACTA1 | 3 | MHO:000115 Peripheral | 1 | 0.33 |
| HGNC:129 ACTA1 | 3 | MHO:000005 Fiber Type 1 Hypertrophic | 1 | 0.33 |
| HGNC:129 ACTA1 | 3 | MHO:000145 PAS Staining: Irregular / Uneven | 1 | 0.33 |
| HGNC:129 ACTA1 | 3 | MHO:000007 Fiber Type 1 Heterogeneous size | 1 | 0.33 |
| HGNC:129 ACTA1 | 3 | MHO:000027 Centralized Nuclei | 1 | 0.33 |
| HGNC:129 ACTA1 | 3 | MHO:000064 Fatty tissue Increase | 1 | 0.33 |
| HGNC:129 ACTA1 | 3 | MHO:000028 Internalized nuclei | 1 | 0.33 |
| HGNC:129 ACTA1 | 3 | MHO:000037 Fuscinophilic material: Granular | 1 | 0.33 |
| HGNC:129 ACTA1 | 3 | MHO:000131 Dark Atrophic Fibre | 1 | 0.33 |
| HGNC:129 ACTA1 | 3 | MHO:000151 Sudan Staining: Abornmal (Lipids Overload) | 1 | 0.33 |
| HGNC:129 ACTA1 | 3 | MHO:000036 Dark clusters | 1 | 0.33 |
| HGNC:129 ACTA1 | 3 | MHO:000003 Abnormal Biopsy | 1 | 0.33 |
| HGNC:129 ACTA1 | 3 | MHO:000125 Single Central Core | 1 | 0.33 |
| HGNC:129 ACTA1 | 3 | MHO:000140 Abnormal Phospholipase Activity Locally | 1 | 0.33 |
| HGNC:129 ACTA1 | 3 | MHO:000090 Acid-Resistant Activity (Type 1) | 1 | 0.33 |
| HGNC:129 ACTA1 | 3 | MHO:000095 Abnormal ATPase activity | 1 | 0.33 |
| HGNC:129 ACTA1 | 3 | MHO:000138 Abnormal Phospholipase+AMP activity | 1 | 0.33 |
| HGNC:7448 MTM1 | 2 | MHO:000013 Unequal Size | 2 | 1.00 |
| HGNC:7448 MTM1 | 2 | MHO:000027 Centralized Nuclei | 2 | 1.00 |
| HGNC:7448 MTM1 | 2 | MHO:000006 Fiber Type 1 Atrophied | 1 | 0.50 |
| HGNC:7448 MTM1 | 2 | MHO:000072 Necklace Fibers | 1 | 0.50 |
| HGNC:7448 MTM1 | 2 | MHO:000060 Lipomatous connective tissue | 1 | 0.50 |
| HGNC:7448 MTM1 | 2 | MHO:000059 Fibrous connective tissue | 1 | 0.50 |
| HGNC:7448 MTM1 | 2 | MHO:000009 Fiber Type 2 Hypertrophic | 1 | 0.50 |
| HGNC:7448 MTM1 | 2 | MHO:000020 Angular | 1 | 0.50 |
| HGNC:7448 MTM1 | 2 | MHO:000025 Annular fibre | 1 | 0.50 |
| HGNC:7448 MTM1 | 2 | MHO:000083 Predominance Fiber Type 1 | 1 | 0.50 |
| HGNC:7448 MTM1 | 2 | MHO:000081 Type Uniformity | 1 | 0.50 |
| HGNC:7448 MTM1 | 2 | MHO:000091 Central ATP activity | 1 | 0.50 |
| HGNC:7448 MTM1 | 2 | MHO:000028 Internalized nuclei | 1 | 0.50 |
| HGNC:7448 MTM1 | 2 | MHO:000104 Targettoide aspect | 1 | 0.50 |
| HGNC:7448 MTM1 | 2 | MHO:000096 Locally Abnormal ATP Activity (Clear Zone) | 1 | 0.50 |
| HGNC:7448 MTM1 | 2 | MHO:000107 Structural Disorganisation | 1 | 0.50 |
| HGNC:10483 RYR1 | 6 | MHO:000027 Centralized Nuclei | 6 | 1.00 |
| HGNC:10483 RYR1 | 6 | MHO:000013 Unequal Size | 6 | 1.00 |
| HGNC:10483 RYR1 | 6 | MHO:000015 No Topography | 5 | 0.83 |
| HGNC:10483 RYR1 | 6 | MHO:000010 Fiber Type 2 Atrophied | 5 | 0.83 |
| HGNC:10483 RYR1 | 6 | MHO:000021 Rounded edge | 5 | 0.83 |
| HGNC:10483 RYR1 | 6 | MHO:000126 Cores with Net Limits | 4 | 0.67 |
| HGNC:10483 RYR1 | 6 | MHO:000124 Peripheral Cores | 4 | 0.67 |
| HGNC:10483 RYR1 | 6 | MHO:000083 Predominance Fiber Type 1 | 4 | 0.67 |
| HGNC:10483 RYR1 | 6 | MHO:000028 Internalized nuclei | 4 | 0.67 |
| HGNC:10483 RYR1 | 6 | MHO:000105 Core-like alveolus | 4 | 0.67 |
| HGNC:10483 RYR1 | 6 | MHO:000009 Fiber Type 2 Hypertrophic | 4 | 0.67 |
| HGNC:10483 RYR1 | 6 | MHO:000022 Fibre segmentation | 3 | 0.50 |
| HGNC:10483 RYR1 | 6 | MHO:000011 Fiber Type 2 Heterogeneous size | 3 | 0.50 |
| HGNC:10483 RYR1 | 6 | MHO:000107 Structural Disorganisation | 3 | 0.50 |
| HGNC:10483 RYR1 | 6 | MHO:000125 Single Central Core | 3 | 0.50 |
| HGNC:10483 RYR1 | 6 | MHO:000127 Cores with Blurred Boundaries | 2 | 0.33 |
| HGNC:10483 RYR1 | 6 | MHO:000005 Fiber Type 1 Hypertrophic | 2 | 0.33 |
| HGNC:10483 RYR1 | 6 | MHO:000046 Purplish appearance | 2 | 0.33 |
| HGNC:10483 RYR1 | 6 | MHO:000128 Cores over the whole Section | 2 | 0.33 |
| HGNC:10483 RYR1 | 6 | MHO:000050 Red Spike | 1 | 0.17 |
| HGNC:10483 RYR1 | 6 | MHO:000143 Abnormal PAS Staining (Overload) | 1 | 0.17 |
| HGNC:10483 RYR1 | 6 | MHO:000114 Central activity | 1 | 0.17 |
| HGNC:10483 RYR1 | 6 | MHO:000003 Abnormal Biopsy | 1 | 0.17 |
| HGNC:10483 RYR1 | 6 | MHO:000060 Lipomatous connective tissue | 1 | 0.17 |
| HGNC:10483 RYR1 | 6 | MHO:000113 Clear zone (pale) | 1 | 0.17 |
| HGNC:10483 RYR1 | 6 | MHO:000036 Dark clusters | 1 | 0.17 |
| HGNC:10483 RYR1 | 6 | MHO:000041 Fuscinophile matrial: Peripherals | 1 | 0.17 |
| HGNC:10483 RYR1 | 6 | MHO:000040 Fuscinophilic material: Centralized | 1 | 0.17 |
| HGNC:10483 RYR1 | 6 | MHO:000062 Interstitial alterations | 1 | 0.17 |
| HGNC:10483 RYR1 | 6 | MHO:000096 Locally Abnormal ATP Activity (Clear Zone) | 1 | 0.17 |
| HGNC:10483 RYR1 | 6 | MHO:000115 Peripheral | 1 | 0.17 |
| HGNC:10483 RYR1 | 6 | MHO:000104 Targettoide aspect | 1 | 0.17 |
| HGNC:7720 NEB | 9 | MHO:000036 Dark clusters | 9 | 1.00 |
| HGNC:7720 NEB | 9 | MHO:000048 Rods | 9 | 1.00 |
| HGNC:7720 NEB | 9 | MHO:000006 Fiber Type 1 Atrophied | 8 | 0.89 |
| HGNC:7720 NEB | 9 | MHO:000013 Unequal Size | 8 | 0.89 |
| HGNC:7720 NEB | 9 | MHO:000083 Predominance Fiber Type 1 | 8 | 0.89 |
| HGNC:7720 NEB | 9 | MHO:000107 Structural Disorganisation | 7 | 0.78 |
| HGNC:7720 NEB | 9 | MHO:000010 Fiber Type 2 Atrophied | 7 | 0.78 |
| HGNC:7720 NEB | 9 | MHO:000151 Sudan Staining: Abornmal (Lipids Overload) | 5 | 0.56 |
| HGNC:7720 NEB | 9 | MHO:000027 Centralized Nuclei | 4 | 0.44 |
| HGNC:7720 NEB | 9 | MHO:000007 Fiber Type 1 Heterogeneous size | 4 | 0.44 |
| HGNC:7720 NEB | 9 | MHO:000136 Local Abnormal COX activity | 3 | 0.33 |
| HGNC:7720 NEB | 9 | MHO:000121 Uncoloured Inclusion Zone | 3 | 0.33 |
| HGNC:7720 NEB | 9 | MHO:000074 Necrosis | 3 | 0.33 |
| HGNC:7720 NEB | 9 | MHO:000064 Fatty tissue Increase | 3 | 0.33 |
| HGNC:7720 NEB | 9 | MHO:000033 Centralized Inclusions | 3 | 0.33 |
| HGNC:7720 NEB | 9 | MHO:000081 Type Uniformity | 3 | 0.33 |
| HGNC:7720 NEB | 9 | MHO:000015 No Topography | 2 | 0.22 |
| HGNC:7720 NEB | 9 | MHO:000045 Fuscinophilic material: Rounded | 2 | 0.22 |
| HGNC:7720 NEB | 9 | MHO:000041 Fuscinophile matrial: Peripherals | 2 | 0.22 |
| HGNC:7720 NEB | 9 | MHO:000152 Sudan Staining: Lipid Droplets | 2 | 0.22 |
| HGNC:7720 NEB | 9 | MHO:000143 Abnormal PAS Staining (Overload) | 1 | 0.11 |
| HGNC:7720 NEB | 9 | MHO:000114 Central activity | 1 | 0.11 |
| HGNC:7720 NEB | 9 | MHO:000054 Central Pale Zone | 1 | 0.11 |
| HGNC:7720 NEB | 9 | MHO:000003 Abnormal Biopsy | 1 | 0.11 |
| HGNC:7720 NEB | 9 | MHO:000174 Normal Situation | 1 | 0.11 |
| HGNC:7720 NEB | 9 | MHO:000005 Fiber Type 1 Hypertrophic | 1 | 0.11 |
| HGNC:7720 NEB | 9 | MHO:000009 Fiber Type 2 Hypertrophic | 1 | 0.11 |
| HGNC:7720 NEB | 9 | MHO:000063 Interstitial Connective Tissue Increase | 1 | 0.11 |
| HGNC:7720 NEB | 9 | MHO:000021 Rounded edge | 1 | 0.11 |
| HGNC:7720 NEB | 9 | MHO:000068 Inflammation | 1 | 0.11 |
| HGNC:7720 NEB | 9 | MHO:000040 Fuscinophilic material: Centralized | 1 | 0.11 |
| HGNC:7720 NEB | 9 | MHO:000037 Fuscinophilic material: Granular | 1 | 0.11 |
| HGNC:7720 NEB | 9 | MHO:000118 Blurred boundaries | 1 | 0.11 |
| HGNC:7720 NEB | 9 | MHO:000113 Clear zone (pale) | 1 | 0.11 |
| HGNC:7720 NEB | 9 | MHO:000034 Peripheral Inclusions | 1 | 0.11 |
| HGNC:7720 NEB | 9 | MHO:000096 Locally Abnormal ATP Activity (Clear Zone) | 1 | 0.11 |
| HGNC:7720 NEB | 9 | MHO:000105 Core-like alveolus | 1 | 0.11 |
| HGNC:7577 MYH7 | 4 | MHO:000125 Single Central Core | 4 | 1.00 |
| HGNC:7577 MYH7 | 4 | MHO:000113 Clear zone (pale) | 4 | 1.00 |
| HGNC:7577 MYH7 | 4 | MHO:000006 Fiber Type 1 Atrophied | 3 | 0.75 |
| HGNC:7577 MYH7 | 4 | MHO:000013 Unequal Size | 3 | 0.75 |
| HGNC:7577 MYH7 | 4 | MHO:000083 Predominance Fiber Type 1 | 3 | 0.75 |
| HGNC:7577 MYH7 | 4 | MHO:000107 Structural Disorganisation | 3 | 0.75 |
| HGNC:7577 MYH7 | 4 | MHO:000096 Locally Abnormal ATP Activity (Clear Zone) | 3 | 0.75 |
| HGNC:7577 MYH7 | 4 | MHO:000123 Core | 2 | 0.50 |
| HGNC:7577 MYH7 | 4 | MHO:000117 Net limits | 2 | 0.50 |
| HGNC:7577 MYH7 | 4 | MHO:000027 Centralized Nuclei | 2 | 0.50 |
| HGNC:7577 MYH7 | 4 | MHO:000010 Fiber Type 2 Atrophied | 2 | 0.50 |
| HGNC:7577 MYH7 | 4 | MHO:000028 Internalized nuclei | 2 | 0.50 |
| HGNC:7577 MYH7 | 4 | MHO:000118 Blurred boundaries | 2 | 0.50 |
| HGNC:7577 MYH7 | 4 | MHO:000126 Cores with Net Limits | 2 | 0.50 |
| HGNC:7577 MYH7 | 4 | MHO:000011 Fiber Type 2 Heterogeneous size | 1 | 0.25 |
| HGNC:7577 MYH7 | 4 | MHO:000114 Central activity | 1 | 0.25 |
| HGNC:7577 MYH7 | 4 | MHO:000009 Fiber Type 2 Hypertrophic | 1 | 0.25 |
| HGNC:7577 MYH7 | 4 | MHO:000020 Angular | 1 | 0.25 |
| HGNC:7577 MYH7 | 4 | MHO:000005 Fiber Type 1 Hypertrophic | 1 | 0.25 |
| HGNC:7577 MYH7 | 4 | MHO:000007 Fiber Type 1 Heterogeneous size | 1 | 0.25 |
| HGNC:7577 MYH7 | 4 | MHO:000128 Cores over the whole Section | 1 | 0.25 |
| HGNC:7577 MYH7 | 4 | MHO:000127 Cores with Blurred Boundaries | 1 | 0.25 |
| HGNC:7577 MYH7 | 4 | MHO:000051 Red Dust | 1 | 0.25 |
| HGNC:7577 MYH7 | 4 | MHO:000037 Fuscinophilic material: Granular | 1 | 0.25 |
| HGNC:7577 MYH7 | 4 | MHO:000044 Fuscinophilic material: Irregular edges | 1 | 0.25 |
| HGNC:7577 MYH7 | 4 | MHO:000105 Core-like alveolus | 1 | 0.25 |
| HGNC:7577 MYH7 | 4 | MHO:000029 Sub-Sarcolemmal Nuclei | 1 | 0.25 |
| HGNC:7577 MYH7 | 4 | MHO:000140 Abnormal Phospholipase Activity Locally | 1 | 0.25 |
| HGNC:7577 MYH7 | 4 | MHO:000124 Peripheral Cores | 1 | 0.25 |
| HGNC:7577 MYH7 | 4 | MHO:000094 Halo activity | 1 | 0.25 |
Vocabulary Frequencies Per Diagnosis
Download Table (.CSV)| Diag | N | Feature | Count | Frequency |
|---|---|---|---|---|
| UNCLEAR | 8 | MHO:000027 Centralized Nuclei | 6 | 0.75 |
| UNCLEAR | 8 | MHO:000006 Fiber Type 1 Atrophied | 5 | 0.62 |
| UNCLEAR | 8 | MHO:000107 Structural Disorganisation | 4 | 0.50 |
| UNCLEAR | 8 | MHO:000048 Rods | 3 | 0.38 |
| UNCLEAR | 8 | MHO:000005 Fiber Type 1 Hypertrophic | 3 | 0.38 |
| UNCLEAR | 8 | MHO:000010 Fiber Type 2 Atrophied | 3 | 0.38 |
| UNCLEAR | 8 | MHO:000083 Predominance Fiber Type 1 | 3 | 0.38 |
| UNCLEAR | 8 | MHO:000028 Internalized nuclei | 3 | 0.38 |
| UNCLEAR | 8 | MHO:000013 Unequal Size | 3 | 0.38 |
| UNCLEAR | 8 | MHO:000007 Fiber Type 1 Heterogeneous size | 2 | 0.25 |
| UNCLEAR | 8 | MHO:000011 Fiber Type 2 Heterogeneous size | 2 | 0.25 |
| UNCLEAR | 8 | MHO:000009 Fiber Type 2 Hypertrophic | 2 | 0.25 |
| UNCLEAR | 8 | MHO:000129 Minicores | 2 | 0.25 |
| UNCLEAR | 8 | MHO:000031 Increase in the number of nuclei | 2 | 0.25 |
| UNCLEAR | 8 | MHO:000040 Fuscinophilic material: Centralized | 2 | 0.25 |
| UNCLEAR | 8 | MHO:000106 Structural Reorganisation | 2 | 0.25 |
| UNCLEAR | 8 | MHO:000059 Fibrous connective tissue | 2 | 0.25 |
| UNCLEAR | 8 | MHO:000072 Necklace Fibers | 2 | 0.25 |
| UNCLEAR | 8 | MHO:000074 Necrosis | 2 | 0.25 |
| UNCLEAR | 8 | MHO:000036 Dark clusters | 2 | 0.25 |
| UNCLEAR | 8 | MHO:000113 Clear zone (pale) | 1 | 0.12 |
| UNCLEAR | 8 | MHO:000008 Fiber Type 2 | 1 | 0.12 |
| UNCLEAR | 8 | MHO:000057 Abnormal Neuromuscular Spindle | 1 | 0.12 |
| UNCLEAR | 8 | MHO:000050 Red Spike | 1 | 0.12 |
| UNCLEAR | 8 | MHO:000051 Red Dust | 1 | 0.12 |
| UNCLEAR | 8 | MHO:000075 Regeneration | 1 | 0.12 |
| UNCLEAR | 8 | MHO:000033 Centralized Inclusions | 1 | 0.12 |
| UNCLEAR | 8 | MHO:000004 Fiber Type 1 | 1 | 0.12 |
| UNCLEAR | 8 | MHO:000073 Peripheral nail stroke | 1 | 0.12 |
| UNCLEAR | 8 | MHO:000060 Lipomatous connective tissue | 1 | 0.12 |
| UNCLEAR | 8 | MHO:000029 Sub-Sarcolemmal Nuclei | 1 | 0.12 |
| UNCLEAR | 8 | MHO:000030 Nuclei with Myotubular Aspects | 1 | 0.12 |
| UNCLEAR | 8 | MHO:000003 Abnormal Biopsy | 1 | 0.12 |
| UNCLEAR | 8 | MHO:000174 Normal Situation | 1 | 0.12 |
| UNCLEAR | 8 | MHO:000135 Abnormal COX activity | 1 | 0.12 |
| UNCLEAR | 8 | MHO:000081 Type Uniformity | 1 | 0.12 |
| UNCLEAR | 8 | MHO:000015 No Topography | 1 | 0.12 |
| UNCLEAR | 8 | MHO:000105 Core-like alveolus | 1 | 0.12 |
| UNCLEAR | 8 | MHO:000122 Peripheral Mitochondrial Accumulation | 1 | 0.12 |
| UNCLEAR | 8 | MHO:000110 Rimmed Sarcolemma | 1 | 0.12 |
| UNCLEAR | 8 | MHO:000109 Irregular Intermyofibrillar Network | 1 | 0.12 |
| UNCLEAR | 8 | MHO:000125 Single Central Core | 1 | 0.12 |
| UNCLEAR | 8 | MHO:000126 Cores with Net Limits | 1 | 0.12 |
| UNCLEAR | 8 | MHO:000127 Cores with Blurred Boundaries | 1 | 0.12 |
| UNCLEAR | 8 | MHO:000128 Cores over the whole Section | 1 | 0.12 |
| UNCLEAR | 8 | MHO:000021 Rounded edge | 1 | 0.12 |
| UNCLEAR | 8 | MHO:000044 Fuscinophilic material: Irregular edges | 1 | 0.12 |
| UNCLEAR | 8 | MHO:000045 Fuscinophilic material: Rounded | 1 | 0.12 |
| UNCLEAR | 8 | MHO:000124 Peripheral Cores | 1 | 0.12 |
| ORPHA:607 Nemaline myopathy | 14 | MHO:000013 Unequal Size | 13 | 0.93 |
| ORPHA:607 Nemaline myopathy | 14 | MHO:000036 Dark clusters | 13 | 0.93 |
| ORPHA:607 Nemaline myopathy | 14 | MHO:000006 Fiber Type 1 Atrophied | 13 | 0.93 |
| ORPHA:607 Nemaline myopathy | 14 | MHO:000083 Predominance Fiber Type 1 | 13 | 0.93 |
| ORPHA:607 Nemaline myopathy | 14 | MHO:000048 Rods | 12 | 0.86 |
| ORPHA:607 Nemaline myopathy | 14 | MHO:000010 Fiber Type 2 Atrophied | 12 | 0.86 |
| ORPHA:607 Nemaline myopathy | 14 | MHO:000107 Structural Disorganisation | 10 | 0.71 |
| ORPHA:607 Nemaline myopathy | 14 | MHO:000151 Sudan Staining: Abornmal (Lipids Overload) | 7 | 0.50 |
| ORPHA:607 Nemaline myopathy | 14 | MHO:000007 Fiber Type 1 Heterogeneous size | 6 | 0.43 |
| ORPHA:607 Nemaline myopathy | 14 | MHO:000081 Type Uniformity | 6 | 0.43 |
| ORPHA:607 Nemaline myopathy | 14 | MHO:000027 Centralized Nuclei | 5 | 0.36 |
| ORPHA:607 Nemaline myopathy | 14 | MHO:000136 Local Abnormal COX activity | 4 | 0.29 |
| ORPHA:607 Nemaline myopathy | 14 | MHO:000064 Fatty tissue Increase | 4 | 0.29 |
| ORPHA:607 Nemaline myopathy | 14 | MHO:000005 Fiber Type 1 Hypertrophic | 3 | 0.21 |
| ORPHA:607 Nemaline myopathy | 14 | MHO:000121 Uncoloured Inclusion Zone | 3 | 0.21 |
| ORPHA:607 Nemaline myopathy | 14 | MHO:000074 Necrosis | 3 | 0.21 |
| ORPHA:607 Nemaline myopathy | 14 | MHO:000041 Fuscinophile matrial: Peripherals | 3 | 0.21 |
| ORPHA:607 Nemaline myopathy | 14 | MHO:000096 Locally Abnormal ATP Activity (Clear Zone) | 3 | 0.21 |
| ORPHA:607 Nemaline myopathy | 14 | MHO:000113 Clear zone (pale) | 3 | 0.21 |
| ORPHA:607 Nemaline myopathy | 14 | MHO:000118 Blurred boundaries | 3 | 0.21 |
| ORPHA:607 Nemaline myopathy | 14 | MHO:000009 Fiber Type 2 Hypertrophic | 3 | 0.21 |
| ORPHA:607 Nemaline myopathy | 14 | MHO:000033 Centralized Inclusions | 3 | 0.21 |
| ORPHA:607 Nemaline myopathy | 14 | MHO:000140 Abnormal Phospholipase Activity Locally | 2 | 0.14 |
| ORPHA:607 Nemaline myopathy | 14 | MHO:000011 Fiber Type 2 Heterogeneous size | 2 | 0.14 |
| ORPHA:607 Nemaline myopathy | 14 | MHO:000114 Central activity | 2 | 0.14 |
| ORPHA:607 Nemaline myopathy | 14 | MHO:000063 Interstitial Connective Tissue Increase | 2 | 0.14 |
| ORPHA:607 Nemaline myopathy | 14 | MHO:000015 No Topography | 2 | 0.14 |
| ORPHA:607 Nemaline myopathy | 14 | MHO:000037 Fuscinophilic material: Granular | 2 | 0.14 |
| ORPHA:607 Nemaline myopathy | 14 | MHO:000105 Core-like alveolus | 2 | 0.14 |
| ORPHA:607 Nemaline myopathy | 14 | MHO:000003 Abnormal Biopsy | 2 | 0.14 |
| ORPHA:607 Nemaline myopathy | 14 | MHO:000045 Fuscinophilic material: Rounded | 2 | 0.14 |
| ORPHA:607 Nemaline myopathy | 14 | MHO:000152 Sudan Staining: Lipid Droplets | 2 | 0.14 |
| ORPHA:607 Nemaline myopathy | 14 | MHO:000034 Peripheral Inclusions | 1 | 0.07 |
| ORPHA:607 Nemaline myopathy | 14 | MHO:000138 Abnormal Phospholipase+AMP activity | 1 | 0.07 |
| ORPHA:607 Nemaline myopathy | 14 | MHO:000028 Internalized nuclei | 1 | 0.07 |
| ORPHA:607 Nemaline myopathy | 14 | MHO:000070 Increase in Endosymal Collagen | 1 | 0.07 |
| ORPHA:607 Nemaline myopathy | 14 | MHO:000051 Red Dust | 1 | 0.07 |
| ORPHA:607 Nemaline myopathy | 14 | MHO:000054 Central Pale Zone | 1 | 0.07 |
| ORPHA:607 Nemaline myopathy | 14 | MHO:000174 Normal Situation | 1 | 0.07 |
| ORPHA:607 Nemaline myopathy | 14 | MHO:000059 Fibrous connective tissue | 1 | 0.07 |
| ORPHA:607 Nemaline myopathy | 14 | MHO:000143 Abnormal PAS Staining (Overload) | 1 | 0.07 |
| ORPHA:607 Nemaline myopathy | 14 | MHO:000020 Angular | 1 | 0.07 |
| ORPHA:607 Nemaline myopathy | 14 | MHO:000117 Net limits | 1 | 0.07 |
| ORPHA:607 Nemaline myopathy | 14 | MHO:000068 Inflammation | 1 | 0.07 |
| ORPHA:607 Nemaline myopathy | 14 | MHO:000044 Fuscinophilic material: Irregular edges | 1 | 0.07 |
| ORPHA:607 Nemaline myopathy | 14 | MHO:000021 Rounded edge | 1 | 0.07 |
| ORPHA:607 Nemaline myopathy | 14 | MHO:000123 Core | 1 | 0.07 |
| ORPHA:607 Nemaline myopathy | 14 | MHO:000040 Fuscinophilic material: Centralized | 1 | 0.07 |
| ORPHA:607 Nemaline myopathy | 14 | MHO:000125 Single Central Core | 1 | 0.07 |
| ORPHA:607 Nemaline myopathy | 14 | MHO:000087 Fibres 1 Grouped | 1 | 0.07 |
| ORPHA:595 Centronuclear myopathy | 6 | MHO:000013 Unequal Size | 6 | 1.00 |
| ORPHA:595 Centronuclear myopathy | 6 | MHO:000083 Predominance Fiber Type 1 | 5 | 0.83 |
| ORPHA:595 Centronuclear myopathy | 6 | MHO:000028 Internalized nuclei | 5 | 0.83 |
| ORPHA:595 Centronuclear myopathy | 6 | MHO:000027 Centralized Nuclei | 5 | 0.83 |
| ORPHA:595 Centronuclear myopathy | 6 | MHO:000107 Structural Disorganisation | 4 | 0.67 |
| ORPHA:595 Centronuclear myopathy | 6 | MHO:000081 Type Uniformity | 3 | 0.50 |
| ORPHA:595 Centronuclear myopathy | 6 | MHO:000021 Rounded edge | 3 | 0.50 |
| ORPHA:595 Centronuclear myopathy | 6 | MHO:000072 Necklace Fibers | 3 | 0.50 |
| ORPHA:595 Centronuclear myopathy | 6 | MHO:000010 Fiber Type 2 Atrophied | 3 | 0.50 |
| ORPHA:595 Centronuclear myopathy | 6 | MHO:000070 Increase in Endosymal Collagen | 2 | 0.33 |
| ORPHA:595 Centronuclear myopathy | 6 | MHO:000030 Nuclei with Myotubular Aspects | 2 | 0.33 |
| ORPHA:595 Centronuclear myopathy | 6 | MHO:000029 Sub-Sarcolemmal Nuclei | 2 | 0.33 |
| ORPHA:595 Centronuclear myopathy | 6 | MHO:000009 Fiber Type 2 Hypertrophic | 2 | 0.33 |
| ORPHA:595 Centronuclear myopathy | 6 | MHO:000091 Central ATP activity | 2 | 0.33 |
| ORPHA:595 Centronuclear myopathy | 6 | MHO:000006 Fiber Type 1 Atrophied | 2 | 0.33 |
| ORPHA:595 Centronuclear myopathy | 6 | MHO:000025 Annular fibre | 1 | 0.17 |
| ORPHA:595 Centronuclear myopathy | 6 | MHO:000059 Fibrous connective tissue | 1 | 0.17 |
| ORPHA:595 Centronuclear myopathy | 6 | MHO:000020 Angular | 1 | 0.17 |
| ORPHA:595 Centronuclear myopathy | 6 | MHO:000063 Interstitial Connective Tissue Increase | 1 | 0.17 |
| ORPHA:595 Centronuclear myopathy | 6 | MHO:000114 Central activity | 1 | 0.17 |
| ORPHA:595 Centronuclear myopathy | 6 | MHO:000060 Lipomatous connective tissue | 1 | 0.17 |
| ORPHA:595 Centronuclear myopathy | 6 | MHO:000003 Abnormal Biopsy | 1 | 0.17 |
| ORPHA:595 Centronuclear myopathy | 6 | MHO:000046 Purplish appearance | 1 | 0.17 |
| ORPHA:595 Centronuclear myopathy | 6 | MHO:000031 Increase in the number of nuclei | 1 | 0.17 |
| ORPHA:595 Centronuclear myopathy | 6 | MHO:000096 Locally Abnormal ATP Activity (Clear Zone) | 1 | 0.17 |
| ORPHA:595 Centronuclear myopathy | 6 | MHO:000015 No Topography | 1 | 0.17 |
| ORPHA:595 Centronuclear myopathy | 6 | MHO:000105 Core-like alveolus | 1 | 0.17 |
| ORPHA:595 Centronuclear myopathy | 6 | MHO:000104 Targettoide aspect | 1 | 0.17 |
| ORPHA:595 Centronuclear myopathy | 6 | MHO:000118 Blurred boundaries | 1 | 0.17 |
| ORPHA:172976 Congenital myopathy with cores | 12 | MHO:000013 Unequal Size | 11 | 0.92 |
| ORPHA:172976 Congenital myopathy with cores | 12 | MHO:000027 Centralized Nuclei | 9 | 0.75 |
| ORPHA:172976 Congenital myopathy with cores | 12 | MHO:000125 Single Central Core | 8 | 0.67 |
| ORPHA:172976 Congenital myopathy with cores | 12 | MHO:000083 Predominance Fiber Type 1 | 8 | 0.67 |
| ORPHA:172976 Congenital myopathy with cores | 12 | MHO:000124 Peripheral Cores | 7 | 0.58 |
| ORPHA:172976 Congenital myopathy with cores | 12 | MHO:000015 No Topography | 7 | 0.58 |
| ORPHA:172976 Congenital myopathy with cores | 12 | MHO:000010 Fiber Type 2 Atrophied | 7 | 0.58 |
| ORPHA:172976 Congenital myopathy with cores | 12 | MHO:000107 Structural Disorganisation | 7 | 0.58 |
| ORPHA:172976 Congenital myopathy with cores | 12 | MHO:000113 Clear zone (pale) | 7 | 0.58 |
| ORPHA:172976 Congenital myopathy with cores | 12 | MHO:000028 Internalized nuclei | 6 | 0.50 |
| ORPHA:172976 Congenital myopathy with cores | 12 | MHO:000126 Cores with Net Limits | 6 | 0.50 |
| ORPHA:172976 Congenital myopathy with cores | 12 | MHO:000006 Fiber Type 1 Atrophied | 5 | 0.42 |
| ORPHA:172976 Congenital myopathy with cores | 12 | MHO:000096 Locally Abnormal ATP Activity (Clear Zone) | 5 | 0.42 |
| ORPHA:172976 Congenital myopathy with cores | 12 | MHO:000105 Core-like alveolus | 5 | 0.42 |
| ORPHA:172976 Congenital myopathy with cores | 12 | MHO:000127 Cores with Blurred Boundaries | 5 | 0.42 |
| ORPHA:172976 Congenital myopathy with cores | 12 | MHO:000128 Cores over the whole Section | 4 | 0.33 |
| ORPHA:172976 Congenital myopathy with cores | 12 | MHO:000009 Fiber Type 2 Hypertrophic | 4 | 0.33 |
| ORPHA:172976 Congenital myopathy with cores | 12 | MHO:000114 Central activity | 4 | 0.33 |
| ORPHA:172976 Congenital myopathy with cores | 12 | MHO:000021 Rounded edge | 4 | 0.33 |
| ORPHA:172976 Congenital myopathy with cores | 12 | MHO:000011 Fiber Type 2 Heterogeneous size | 3 | 0.25 |
| ORPHA:172976 Congenital myopathy with cores | 12 | MHO:000022 Fibre segmentation | 3 | 0.25 |
| ORPHA:172976 Congenital myopathy with cores | 12 | MHO:000115 Peripheral | 2 | 0.17 |
| ORPHA:172976 Congenital myopathy with cores | 12 | MHO:000129 Minicores | 2 | 0.17 |
| ORPHA:172976 Congenital myopathy with cores | 12 | MHO:000005 Fiber Type 1 Hypertrophic | 2 | 0.17 |
| ORPHA:172976 Congenital myopathy with cores | 12 | MHO:000095 Abnormal ATPase activity | 2 | 0.17 |
| ORPHA:172976 Congenital myopathy with cores | 12 | MHO:000062 Interstitial alterations | 1 | 0.08 |
| ORPHA:172976 Congenital myopathy with cores | 12 | MHO:000029 Sub-Sarcolemmal Nuclei | 1 | 0.08 |
| ORPHA:172976 Congenital myopathy with cores | 12 | MHO:000050 Red Spike | 1 | 0.08 |
| ORPHA:172976 Congenital myopathy with cores | 12 | MHO:000145 PAS Staining: Irregular / Uneven | 1 | 0.08 |
| ORPHA:172976 Congenital myopathy with cores | 12 | MHO:000063 Interstitial Connective Tissue Increase | 1 | 0.08 |
| ORPHA:172976 Congenital myopathy with cores | 12 | MHO:000003 Abnormal Biopsy | 1 | 0.08 |
| ORPHA:172976 Congenital myopathy with cores | 12 | MHO:000143 Abnormal PAS Staining (Overload) | 1 | 0.08 |
| ORPHA:172976 Congenital myopathy with cores | 12 | MHO:000059 Fibrous connective tissue | 1 | 0.08 |
| ORPHA:172976 Congenital myopathy with cores | 12 | MHO:000118 Blurred boundaries | 1 | 0.08 |
| ORPHA:172976 Congenital myopathy with cores | 12 | MHO:000060 Lipomatous connective tissue | 1 | 0.08 |
| ORPHA:172976 Congenital myopathy with cores | 12 | MHO:000131 Dark Atrophic Fibre | 1 | 0.08 |
| ORPHA:172976 Congenital myopathy with cores | 12 | MHO:000037 Fuscinophilic material: Granular | 1 | 0.08 |
| ORPHA:172976 Congenital myopathy with cores | 12 | MHO:000040 Fuscinophilic material: Centralized | 1 | 0.08 |
| ORPHA:172976 Congenital myopathy with cores | 12 | MHO:000041 Fuscinophile matrial: Peripherals | 1 | 0.08 |
| ORPHA:172976 Congenital myopathy with cores | 12 | MHO:000036 Dark clusters | 1 | 0.08 |
| ORPHA:172976 Congenital myopathy with cores | 12 | MHO:000094 Halo activity | 1 | 0.08 |
| ORPHA:172976 Congenital myopathy with cores | 12 | MHO:000046 Purplish appearance | 1 | 0.08 |
| ORPHA:172976 Congenital myopathy with cores | 12 | MHO:000081 Type Uniformity | 1 | 0.08 |
| ORPHA:172976 Congenital myopathy with cores | 12 | MHO:000090 Acid-Resistant Activity (Type 1) | 1 | 0.08 |
| ORPHA:172976 Congenital myopathy with cores | 12 | MHO:000104 Targettoide aspect | 1 | 0.08 |
| ORPHA:172976 Congenital myopathy with cores | 12 | MHO:000117 Net limits | 1 | 0.08 |
| ORPHA:172976 Congenital myopathy with cores | 12 | MHO:000116 Crescent shape | 1 | 0.08 |
| ORPHA:172976 Congenital myopathy with cores | 12 | MHO:000123 Core | 1 | 0.08 |